Enjoy complimentary customisation on priority with our Enterprise License!
The respiratory devices market share in Australia is expected to increase by USD 458.32 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.44%.
This respiratory devices market in Australia research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers respiratory devices market segmentation in Australia by end-user (hospitals, clinics, and ambulatory care services) and type (diagnostic and monitoring devices, therapeutic devices, and disposables). The respiratory devices market in Australia report also offers information on several market vendors, including Bellavista Medical ANZ, Bird Healthcare Pty Ltd, Chart Industries Inc., Dragerwerk AG and Co. KGaA, Fairmont Medical Products Pty Ltd., Fisher and Paykel Healthcare Corp. Ltd., General Electric Co., GlaxoSmithKline Plc, Invacare Corp, and Medical Depot Inc. among others.
Download the Free Report Sample to Unlock the Respiratory Devices Market Size in Australia for the Forecast Period and Other Important Statistics
The increase in patient awareness is notably driving the respiratory devices market growth in Australia, although factors such as high costs of respiratory diagnostic products may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the respiratory devices industry in Australia. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Respiratory Devices Market Driver in Australia
One of the key factors driving growth in the respiratory devices market in Australia is the increase in patient awareness. Over the years, awareness and understanding of respiratory diseases have increased. The incidence of respiratory disorders has increased significantly; the disease is expected to be the third leading cause of death in the future. The early detection of disease with treatment and smoking cessation counseling can control respiratory disorders, driving the demand for upper respiratory tract infection treatment. Community leaders, policymakers, and government agencies are working in collaboration to create patient awareness about respiratory diseases. The National Institutes of Health (NIH) has taken several initiatives to raise awareness about respiratory disorders. The National Heart, Lung, and Blood Institute (NHLBI) initiated the National Asthma Education and Prevention Program (NAEPP) to raise awareness about the effective treatment and prevention of asthma. Such efforts for increasing awareness of respiratory diseases and their available treatment and diagnostic options will drive market growth during the forecast period.
Key Respiratory Devices Market Trend in Australia
The expanding research through new clinical trials and approaches is another factor supporting the respiratory devices market share growth in Australia. Significant research is underway to develop an ideal curative approach for treating respiratory diseases, such as COPD, RSV, and COVID-19. Researchers are identifying molecular targets that lead to disease progression in diseases such as COPD. The identification of molecular targets is necessary to develop novel biologic therapies, such as monoclonal antibodies, which can target the physiological proteins that are responsible for disease progression. Although some monoclonal antibodies had initially failed to comply with the regulatory guidelines, there are other similar products in the pipeline for COPD. Apart from clinical trials for several testing procedures that may enter the market or are in the registration phase, there are novel small molecular approaches that hold promising potential for the treatment of COPD and COVID-19, including the approval of respiratory devices or assays. These advancements will drive the growth of the market during the forecast period.
Key Respiratory Devices Market Challenge in Australia
The high costs of respiratory diagnostic products will be a major challenge for the respiratory devices market in Australia during the forecast period. The respiratory devices market in Australia is growing at a steady pace. However, the high costs associated with molecular diagnostic products to test respiratory system viruses such as influenza (flu) virus and respiratory syncytial virus (RSV) pose a challenge in price-sensitive markets such as developing economies. Also, the increasing demand for molecular testing products for respiratory diseases is hampered by their high costs. The diagnosis and treatment of respiratory infections also include indirect costs such as hospitalization, which can increase the overall costs for the diagnosis and treatment of respiratory diseases. Hospitals and clinics mostly prefer molecular testing to ensure the accuracy of test results and reduce the chances of re-admission, thereby increasing the cost of respiratory devices. Such factors act as a barrier for the respiratory devices market in Australia which, in turn, is expected to negatively impact the growth of the market.
This respiratory devices market in Australia analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global respiratory devices market in Australia as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the respiratory devices market in Australia during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the respiratory devices market in Australia encompasses successful business strategies deployed by the key vendors. The respiratory devices market in Australia is fragmented and the vendors are deploying growth strategies such as M&A and partnerships, new product launches, and online and brick-and-mortar sales of their products to expand their product portfolios and geographical reach to compete in the market.
Invacare Corp - The company offers respiratory devices that are useful for patients with health disorders and failure in respiratory functions, under the brand name of Invacare.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The respiratory devices market in Australia forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the respiratory devices market in Australia, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
The value chain of the healthcare equipment market includes the following core components:
The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.
***1. Executive Summary
**1.1 Market Overview
*Exhibit 01: Key Finding 1
*Exhibit 02: Key Finding 2
*Exhibit 03: Key Finding 6
*Exhibit 04: Key Finding 5
*Exhibit 05: Key Finding 7
***2. Market Landscape
**2.1 Market ecosystem
*2.1.1 Parent market
*Exhibit 06: Parent market
*Exhibit 07: Market Characteristics
**2.2 Value chain analysis
*Exhibit 08: Value chain analysis: Healthcare Equipment
*2.2.1 Research and development
*2.2.2 Inputs
*2.2.3 Operations
*2.2.4 Distribution
*2.2.5 Marketing and sales
*2.2.6 Post-sales and services
*2.2.7 Industry innovations
***3. Market Sizing
**3.1 Market definition
*Exhibit 09: Offerings of vendors included in the market definition
**3.2 Market segment analysis
*Exhibit 10: Market segments
**3.3 Market size 2021
**3.4 Market outlook: Forecast for 2021 - 2026
*3.4.1 Estimating growth rates for emerging and high-growth markets
*3.4.2 Estimating growth rates for mature markets
*Exhibit 11: Global - Market size and forecast 2021 - 2026 ($ million)
*Exhibit 12: Global market: Year-over-year growth 2021 - 2026 (%)
***4. Five Forces Analysis
**4.1 Five Forces Summary
*Exhibit 13: Five forces analysis 2021 & 2026
**4.2 Bargaining power of buyers
*Exhibit 14: Bargaining power of buyers
**4.3 Bargaining power of suppliers
*Exhibit 15: Bargaining power of suppliers
**4.4 Threat of new entrants
*Exhibit 16: Threat of new entrants
**4.5 Threat of substitutes
*Exhibit 17: Threat of substitutes
**4.6 Threat of rivalry
*Exhibit 18: Threat of rivalry
**4.7 Market condition
*Exhibit 19: Market condition - Five forces 2021
***5. Market Segmentation by End-user
**5.1 Market segments
*The segments covered in this chapter are:
*Exhibit 20: End-user - Market share 2021-2026 (%)
**5.2 Comparison by End-user
*Exhibit 21: Comparison by End-user
**5.3 Hospitals - Market size and forecast 2021-2026
*Exhibit 22: Hospitals - Market size and forecast 2021-2026 ($ million)
*Exhibit 23: Hospitals - Year-over-year growth 2021-2026 (%)
**5.4 Clinics - Market size and forecast 2021-2026
*Exhibit 24: Clinics - Market size and forecast 2021-2026 ($ million)
*Exhibit 25: Clinics - Year-over-year growth 2021-2026 (%)
**5.5 Ambulatory care services - Market size and forecast 2021-2026
*Exhibit 26: Ambulatory care services - Market size and forecast 2021-2026 ($ million)
*Exhibit 27: Ambulatory care services - Year-over-year growth 2021-2026 (%)
**5.6 Market opportunity by End-user
*Exhibit 28: Market opportunity by End-user
***6. Market Segmentation by Type
**6.1 Market segments
*The segments covered in this chapter are:
*Exhibit 29: Type - Market share 2021-2026 (%)
**6.2 Comparison by Type
*Exhibit 30: Comparison by Type
**6.3 Diagnostic and monitoring devices - Market size and forecast 2021-2026
*Exhibit 31: Diagnostic and monitoring devices - Market size and forecast 2021-2026 ($ million)
*Exhibit 36: Full truckload - Year-over-year growth 2021-2026 (%)
**6.4 Therapeutic devices - Market size and forecast 2021-2026
*Exhibit 33: Therapeutic devices - Market size and forecast 2021-2026 ($ million)
*Exhibit 34: Therapeutic devices - Year-over-year growth 2021-2026 (%)
**6.5 Disposables - Market size and forecast 2021-2026
*Exhibit 35: Disposables - Market size and forecast 2021-2026 ($ million)
*Exhibit 36: Disposables - Year-over-year growth 2021-2026 (%)
**6.6 Market opportunity by Type
*Exhibit 37: Market opportunity by Type
***7. Customer Landscape
**7.1 Overview
*Exhibit 38: Customer landscape
***8. Drivers, Challenges, and Trends
**8.1 Market drivers
*8.1.1 Increase in patient awareness
*8.1.2 Increasing prevalence of respiratory disorders
*8.1.3 Increasing research on combination therapies
**8.2 Market challenges
*8.2.1 High costs of respiratory diagnostic products
*8.2.2 Stringent regulations associated with medical imaging equipment
*8.2.3 Lack of skilled and trained professionals in laboratories
*Exhibit 39: Impact of drivers and challenges
**8.3 Market trends
*8.3.1 Expanding research through new clinical trials and approaches
*8.3.2 Integration of AI with medical imaging
*8.3.3 Initiatives by government and non-profit organizations to diagnose Respiratory Syncytial Virus (RSV)
***9. Vendor Landscape
**9.1 Overview
*Exhibit 40: Vendor landscape
**9.2 Landscape disruption
*Exhibit 41: Landscape disruption
*Exhibit 42: Industry risks
**9.3 Competitive landscape
***10. Vendor Analysis
**10.1 Vendors covered
*Exhibit 43: Vendors covered
**10.2 Market positioning of vendors
*Exhibit 44: Market positioning of vendors
**10.3 Bellavista Medical ANZ
*Exhibit 45: Bellavista Medical ANZ - Overview
*Exhibit 46: Bellavista Medical ANZ - Product and service
*Exhibit 47: Bellavista Medical ANZ - Key offerings
**10.4 Bird Healthcare Pty Ltd
*Exhibit 48: Bird Healthcare Pty Ltd - Overview
*Exhibit 49: Bird Healthcare Pty Ltd - Product and service
*Exhibit 50: Bird Healthcare Pty Ltd - Key offerings
**10.5 Chart Industries Inc.
*Exhibit 51: Chart Industries Inc. - Overview
*Exhibit 52: Chart Industries Inc. - Business segments
*Exhibit 53: Chart Industries Inc. - Key offerings
*Exhibit 54: Chart Industries Inc. – Key news
*Exhibit 55: Chart Industries Inc. - Segment focus
**10.6 Dragerwerk AG and Co. KGaA
*Exhibit 57: Dragerwerk AG and Co. KGaA - Business segments
*Exhibit 58: Dragerwerk AG and Co. KGaA - Key offerings
*Exhibit 59: Dragerwerk AG and Co. KGaA - Segment focus
**10.7 Fairmont Medical Products Pty Ltd.
*Exhibit 60: Fairmont Medical Products Pty Ltd. - Overview
*Exhibit 61: Fairmont Medical Products Pty Ltd. - Product and service
*Exhibit 62: Fairmont Medical Products Pty Ltd. - Key offerings
**10.8 Fisher and Paykel Healthcare Corp. Ltd.
*Exhibit 63: Fisher and Paykel Healthcare Corp. Ltd. - Overview
*Exhibit 64: Fisher and Paykel Healthcare Corp. Ltd. - Business segments
*Exhibit 65: Fisher and Paykel Healthcare Corp. Ltd. - Key offerings
*Exhibit 66: Fisher and Paykel Healthcare Corp. Ltd. - Segment focus
**10.9 General Electric Co.
*Exhibit 67: General Electric Co. - Overview
*Exhibit 68: General Electric Co. - Business segments
*Exhibit 69: General Electric Co. - Key offerings
*Exhibit 69: General Electric Co. - Key offerings
*Exhibit 71: General Electric Co. - Segment focus
**10.10 GlaxoSmithKline Plc
*Exhibit 72: GlaxoSmithKline Plc - Overview
*Exhibit 73: GlaxoSmithKline Plc - Business segments
*Exhibit 74: GlaxoSmithKline Plc - Key offerings
*Exhibit 75: GlaxoSmithKline Plc – Key news
*Exhibit 76: GlaxoSmithKline Plc - Segment focus
**10.11 Invacare Corp
*Exhibit 77: Invacare Corp - Overview
*Exhibit 78: Invacare Corp - Business segments
*Exhibit 79: Invacare Corp - Key offerings
*Exhibit 80: Invacare Corp – Key news
*Exhibit 81: Invacare Corp - Segment focus
**10.12 Medical Depot Inc.
*Exhibit 82: Medical Depot Inc. - Overview
*Exhibit 83: Medical Depot Inc. - Product and service
*Exhibit 84: Medical Depot Inc. - Key offerings
***11. Appendix
**11.1 Scope of the report
*11.1.1 ????Market definition
*11.1.2 Objective
*11.1.3 Notes and caveats
**11.2 Currency conversion rates for US$
*Exhibit 85: Currency conversion rates for US$
**11.3 Research Methodology
*Exhibit 86: Research Methodology
*Exhibit 87: Validation techniques employed for market sizing
*Exhibit 88: Information sources
**11.4 List of abbreviations
*Exhibit 89: List of abbreviations
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.